Application 219691
- Type
- ANDA
- Sponsor
- ABON PHARMS LLC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ERYTHROMYCIN | ERYTHROMYCIN | TABLET;ORAL | 250MG | No | No |
| 002 | ERYTHROMYCIN | ERYTHROMYCIN | TABLET;ORAL | 500MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A219691-001 | ERYTHROMYCIN | ERYTHROMYCIN | 250MG | TABLET / ORAL | AB | 2025-09-23 | |
| A219691-002 | ERYTHROMYCIN | ERYTHROMYCIN | 500MG | TABLET / ORAL | AB | 2025-09-23 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A219691-001 | AB |
| A219691-002 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A219691-001 | ERYTHROMYCIN | 250MG | TABLET / ORAL | AB | 2025-09-23 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A219691-002 | ERYTHROMYCIN | 500MG | TABLET / ORAL | AB | 2025-09-23 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A219691-001 | ERYTHROMYCIN | 250MG | TABLET / ORAL | AB | 2025-09-23 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A219691-002 | ERYTHROMYCIN | 500MG | TABLET / ORAL | AB | 2025-09-23 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A219691-001 | ERYTHROMYCIN | 250MG | TABLET / ORAL | AB | 2025-09-23 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A219691-002 | ERYTHROMYCIN | 500MG | TABLET / ORAL | AB | 2025-09-23 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A219691-001 | ERYTHROMYCIN | 250MG | TABLET / ORAL | AB | 2025-09-23 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A219691-002 | ERYTHROMYCIN | 500MG | TABLET / ORAL | AB | 2025-09-23 | 31067a03dcf5… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219691-001 | ERYTHROMYCIN | 250MG | TABLET / ORAL | AB | 2025-09-23 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219691-002 | ERYTHROMYCIN | 500MG | TABLET / ORAL | AB | 2025-09-23 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A219691-001 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A219691-002 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A219691-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A219691-002 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A219691-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A219691-002 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A219691-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A219691-002 | AB | 1 | 31067a03dcf5… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219691-001 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219691-002 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Erythromycin | ERYTHROMYCIN | Wilshire Pharmaceuticals | e9b5abbb-2952-44ce-8cbb-415d9be23df4 | 2024-12-13 | Warnings, Adverse reactions | Erythromycin ERYTHROMYCIN |
| Erythromycin | ERYTHROMYCIN | Amneal Pharmaceuticals NY LLC | bb641ed4-8093-4e15-9cb9-8921b1093d50 | 2024-12-10 | Warnings, Adverse reactions | Erythromycin ERYTHROMYCIN |
| ERYTHROMYCIN | ERYTHROMYCIN | Golden State Medical Supply, Inc. | 0c0560be-fb11-509d-e063-6394a90ab6f7 | 2024-11-25 | Warnings, Adverse reactions | ERYTHROMYCIN ERYTHROMYCIN |
| ERYTHROMYCIN | ERYTHROMYCIN | Torrent Pharmaceuticals Limited | 66b0d891-8756-43d1-b046-6dba787dd96f | 2024-10-17 | Warnings, Adverse reactions | ERYTHROMYCIN ERYTHROMYCIN |
| erythromycin | ERYTHROMYCIN | Bryant Ranch Prepack | 00c4f27e-59e2-4173-99b1-59dd295e83de | 2024-10-11 | Warnings, Adverse reactions | erythromycin ERYTHROMYCIN |
| Erythromycin | ERYTHROMYCIN | NuCare Pharmaceuticals,Inc. | 5568ade8-bdc2-1a32-e054-00144ff8d46c | 2024-08-14 | Adverse reactions | Erythromycin ERYTHROMYCIN |
| Erythromycin | ERYTHROMYCIN | Teva Pharmaceuticals USA, Inc. | 75a0bd5a-d09f-483b-bfd8-f8343b149eb2 | 2024-08-01 | Warnings, Adverse reactions | Erythromycin ERYTHROMYCIN |
| erythromycin | ERYTHROMYCIN | NuCare Pharmaceuticals,Inc. | 8349b4ec-3ca6-bdb6-e053-2a91aa0a8b63 | 2024-06-14 | Warnings, Adverse reactions | erythromycin ERYTHROMYCIN |
| erythromycin | ERYTHROMYCIN | NuCare Pharmaceuticals,Inc. | 84119a8f-78d1-2882-e053-2a91aa0a6faa | 2024-06-14 | Adverse reactions | erythromycin ERYTHROMYCIN |
| Erythromycin | ERYTHROMYCIN | NuCare Pharmaceuticals,Inc. | 6296e2ed-334c-b9af-e053-2991aa0aae0c | 2024-06-06 | Adverse reactions | Erythromycin ERYTHROMYCIN |
| Erythromycin | ERYTHROMYCIN | Zydus Pharmaceuticals USA Inc. | 0277341c-8513-4317-9334-c242f97630c1 | 2024-03-20 | Warnings, Adverse reactions | Erythromycin ERYTHROMYCIN |
| Erythromycin Ethylsuccinate | ERYTHROMYCIN | Amneal Pharmaceuticals NY LLC | 596fa019-b0eb-4e57-93ff-195a765a2e91 | 2023-12-29 | Warnings, Adverse reactions | ERYTHROMYCIN |
| Erythromycin | ERYTHROMYCIN | Modavar Pharmaceuticals LLC | bc3d091b-1fc8-4f7a-a3c2-8ede87f5faa0 | 2023-12-23 | Warnings, Adverse reactions | Erythromycin ERYTHROMYCIN |
| Erythromycin | ERYTHROMYCIN | Cadila Pharmaceuticals Limited | fae8fc38-3c60-43b8-a0f9-2c50df332505 | 2023-12-22 | Warnings, Adverse reactions | Erythromycin ERYTHROMYCIN |
| Erythromycin | ERYTHROMYCIN | Fera Pharmaceuticals, LLC | be59bb85-8ef4-4f9e-85e5-c05662ecd1ee | 2023-10-26 | Erythromycin ERYTHROMYCIN | |
| Erythromycin | ERYTHROMYCIN | ARMAS PHARMACEUTICALS INC. | 07fdeac5-f690-d74b-e063-6394a90a5c5b | 2023-10-23 | Adverse reactions | Erythromycin ERYTHROMYCIN |
| erythromycin | ERYTHROMYCIN | Asclemed USA, Inc. | 6186510d-62ca-4083-9895-8d028d71b510 | 2023-09-12 | Adverse reactions | erythromycin ERYTHROMYCIN |
| Erythromycin | ERYTHROMYCIN | Alembic Pharmaceuticals Limited | 904b9ab6-9a2a-47f3-8a38-04920ce696e0 | 2023-08-29 | Warnings, Adverse reactions | Erythromycin ERYTHROMYCIN |
| Erythromycin | ERYTHROMYCIN | Alembic Pharmaceuticals Inc. | 383f9011-a3e0-4d7d-b058-5f8ab319dc8c | 2023-08-25 | Warnings, Adverse reactions | Erythromycin ERYTHROMYCIN |
| Erythromycin | ERYTHROMYCIN | Bryant Ranch Prepack | b7d11564-c92d-4eed-bdd9-8fc355e7dfc7 | 2023-08-16 | Warnings, Adverse reactions | Erythromycin ERYTHROMYCIN |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.